<DOC>
	<DOCNO>NCT00656656</DOCNO>
	<brief_summary>Pemphigus severe autoimmune blister disease mediate circulate antibody certain protein important maintain skin integrity . Protein A immunoadsorption dialysis-like technique selectively remove antibody patient 's blood . Rituximab synthetic antibody capable destroying B cell . B cell responsible production antibody patient blood , turn , lead clinical sign pemphigus . Dexamethasone pulse therapy high-dose short-term corticosteroid therapy may use suppress autoantibody production pemphigus . While three therapy use treat pemphigus , none show effective case . The hypothesis study combination protein A immunoadsorption , rituximab dexamethasone effective either treatment alone achieve rapid durable improvement cure patient pemphigus .</brief_summary>
	<brief_title>Immunoadsorption , Dexamethasone Pulse Therapy Rituximab Pemphigus</brief_title>
	<detailed_description />
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Diagnosis pemphigus confirm immunofluorescence desmoglein ELISA . Severe disease past treatment ( ) effective past treatment ( ) tolerate . General condition poor tolerate immunoadsorption treatment . Severe dementia psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pemphigus</keyword>
	<keyword>rituximab</keyword>
	<keyword>immunoadsorption</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>treatment</keyword>
	<keyword>management</keyword>
</DOC>